Highlights
- Sales over the Year and quarter: The company experienced a substantial growth of 5.69 % in the past year, decrease in net sales/revenue by -5.18 %.
- Income over the Year and quarter: There has been either a marginal increase or a decline in other income over the past year which is 9.39 %. Marginal decrease of -12.41% in other income during this quarter.
- Profit over the Year and quarter: Significant improvement in profitability for Alkem Laboratories Limited. Notable increase of 27.54 % in net profit Year to Year, Alkem Laboratories Limited’s profitability dropped by -35.55 % Quarter to Quarter.
- EPS over the Year and quarter: EPS increased by 27.55 % Year to Year. EPS decreased by -35.55 % in previous quarter. Analysis needed for shareholder value.
| Metrics | Previous Year | Previous Quarter | Current Quarter | Quarter to Quarter Difference | Year to Year Difference |
|---|---|---|---|---|---|
| Sales | Rs. 2237.99 Cr | Rs. 2494.59 Cr | Rs. 2365.37 Cr | -5.18 % | + 5.69 % |
| Expenses | Rs. 1906 Cr | Rs. 1925.33 Cr | Rs. 1957.85 Cr | + 1.69 % | + 2.72 % |
| Operating Profit | Rs. 331.99 Cr | Rs. 569.26 Cr | Rs. 407.52 Cr | -28.41 % | + 22.75 % |
| OPM % | 14.83 % | 22.82 % | 17.23 % | -5.59 % | + 2.4 % |
| Other Income | Rs. 76.6 Cr | Rs. 95.66 Cr | Rs. 83.79 Cr | -12.41 % | + 9.39 % |
| Interest | Rs. 21.74 Cr | Rs. 21.11 Cr | Rs. 20.68 Cr | -2.04 % | -4.88 % |
| Depreciation | Rs. 57.16 Cr | Rs. 58.12 Cr | Rs. 69.1 Cr | + 18.89 % | + 20.89 % |
| Profit before tax | Rs. 329.69 Cr | Rs. 585.69 Cr | Rs. 401.53 Cr | -31.44 % | + 21.79 % |
| Tax % | 22.72 % | 5.64 % | 16.46 % | + 10.82 % | -6.26 % |
| Net Profit | Rs. 254.79 Cr | Rs. 504.23 Cr | Rs. 324.97 Cr | -35.55 % | + 27.54 % |
| EPS in Rs | Rs. 21.31 | Rs. 42.17 | Rs. 27.18 | -35.55 % | + 27.55 % |
Today, we’re looking at Alkem Laboratories Limited’s financial performance for the Q4(Mar 2024).Starting with the top line, the company reported a robust year-over-year sales growth of 5.69 %. However, it did see a marginal slip of -5.18 % from the previous quarter. Expenses ticked up slightly by 1.69 % quarter-on-quarter, aligning with the annual rise of 2.72 %. Operating profit, while up 22.75 % compared to last year, faced a quarter-on-quarter dip of -28.41 %, signaling a short-term contraction in margins.
The Operating Profit Margin (OPM) % echoes this narrative, showing resilience on an annual basis with an increase of 2.4 %, but a shrinkage of -5.59 % sequentially. Other income fell by -12.41 % compared to the last quarter, despite an annual growth of 9.39 %. Interest expenses dropped significantly by -2.04 % from the previous quarter, yet the year-over-year decrease remains at a moderate -4.88 %. Depreciation costs climbed by 18.89 % quarter-on-quarter, whereas on an annual scale, they saw an increase of 20.89 %. Profit before tax grew annually by 21.79 % but saw a reduction from the preceding quarter by -31.44 %.
Tax expenses as a percentage of profits decreased slightly by -6.26 % compared to last year, with a more notable quarter-on-quarter increase of 10.82 %. Net profit rose by 27.54 % year-on-year but witnessed a -35.55 % contraction from the last quarter. And finally, Earnings Per Share (EPS) displayed an annual uptick of 27.55 % but a quarterly fall of -35.55 %. In summary, Alkem Laboratories Limited’s annual performance indicates steady growth, although the quarter-on-quarter figures suggest some areas may require strategic attention.
| Metrics | Previous Year | Previous Quarter | Current Quarter | Quarter to Quarter Difference | Year to Year Difference |
|---|---|---|---|---|---|
| Sales | Rs. 2237.99 Cr | Rs. 2494.59 Cr | Rs. 2365.37 Cr | -5.18 % | + 5.69 % |
| Expenses | Rs. 1906 Cr | Rs. 1925.33 Cr | Rs. 1957.85 Cr | + 1.69 % | + 2.72 % |
| Operating Profit | Rs. 331.99 Cr | Rs. 569.26 Cr | Rs. 407.52 Cr | -28.41 % | + 22.75 % |
| Net Profit | Rs. 254.79 Cr | Rs. 504.23 Cr | Rs. 324.97 Cr | -35.55 % | + 27.54 % |
| EPS in Rs | Rs. 21.31 | Rs. 42.17 | Rs. 27.18 | -35.55 % | + 27.55 % |
In reviewing Alkem Laboratories Limited’s 2024(Q4) financial snapshot, key trends emerge, shedding light on the company’s performance.Sales saw a robust 5.69 % year-on-year growth, although there was a slight dip of -5.18 % from the previous quarter. Expenses rose by 2.72 % compared to the previous year, with a 1.69 % increase quarter-on-quarter. Operating Profit surged by 22.75 % annually, and saw a -28.41 % decrease from the last quarter.
Net Profit showed yearly increase of 27.54 %, and experienced a -35.55 % decrease from the previous quarter. Earnings Per Share (EPS) rose by 27.55 % annually, however dipped by -35.55 % compared to the last quarter. In essence, while Alkem Laboratories Limited exhibits strong annual growth indicators, short-term fluctuations suggest the need for agile strategies to navigate market dynamics effectively. That’s all for now in the financial sector.
